Endpoints News· Elizabeth Cairns·· 2 小时前AI 评分42
AstraZeneca 称重组或致研发削减、试验转向新兴市场
AstraZeneca says reorg could mean R&D cuts and trials shifted to emerging markets
AI 导读
AstraZeneca 表示新一轮重组计划可能涉及研发削减和裁员，并将部分临床试验转移至新兴市场。公司管理层在电话会上暗示了成本削减与岗位流失的可能落点。
正文 · 原文
AstraZeneca’s leadership hinted at where the cost cuts and job losses from the company’s new restructuring program might fall on a call …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news